Holy Name In The News
Contact Us
Dr. Ari Eckman, endocrinologist and medical director of Endocrinology services at Holy Name shares his thoughts on the study.
Photo is courtesy of Cameron Whitman/Stocksy
Holy Name was the first site to open a clinical trial for a promising targeted drug therapy for patients with ovarian cancer that returned within six months of platinum-based therapy.
Dr. Asher Goldstein shares new breakthroughs to ease low back pain.
Photo is courtesy of Jewish Link of Bergen County
An overview of Holy Name Medical Center’s Orthopedics
Holy Name Medical Center has debuted Persona IQ's smart knee replacement technology. Persona IQ is the first implantable knee replacement device that allows for remote patient monitoring and data collection, and it is the only smart knee implant with De Novo status from the FDA for total knee replacements.
Holy Name Medical Center will receive a $3.3 million appropriation to launch a new residency program aimed at addressing a critical shortage of physicians. Through the new Graduate Medical Education Program, the Teaneck hospital intends to train 90 doctors per year in clinical specialties including Internal Medicine, psychiatry, general surgery, obstetrics and gynecology, orthopedics, nephrology and palliative care.
Tracee Yablon Brenner RD, HHC, CLT, Outpatient Integrative Dietitian Project Coordinator at Holy Name discusses what chocolate cravings may indicate about your health.
ROI reports on a clinical trial that began at Holy Name - and how the ovarian cancer therapy now has been approved by the U.S. Food and Drug Administration.
Photo is courtesy of Linda Lindner
Dr. Suraj Saggar, Chief of Infectious Disease, shares his thoughts on new mask mandates and Narcan Seeking Approval for OTC Sales.
Dr. Charles Vialotti, Medical Director at Villa Marie Claire Residential Hospice at Holy Name, shares the importance of dying with dignity.
